Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heliocare South Africa is a leading provider of advanced photoprotection products, operating as a key brand under the Spanish pharmaceutical company Cantabria Labs. The brand is renowned for its Fernblock technology, a patented natural extract from the fern Polypodium leucotomos, which provides comprehensive protection against solar radiation and oxidative stress. In the South African market, Heliocare is distributed by Genop Healthcare, a subsidiary of Adcock Ingram, and is widely utilized by medical professionals for the management of skin health and the prevention of photo-induced damage. The product portfolio includes a wide range of topical sunscreens and oral supplements designed to protect the skin from UVA, UVB, visible light, and infrared radiation. Heliocare is recognized for its commitment to scientific research, with its efficacy backed by numerous clinical studies published in leading dermatological journals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heliocare South Africa.